HER2-NEGATIVE
Clinical trials for HER2-NEGATIVE explained in plain language.
Never miss a new study
Get alerted when new HER2-NEGATIVE trials appear
Sign up with your email to follow new studies for HER2-NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Tough-to-Treat stomach cancers
Disease control Recruiting nowThis Phase 2 trial is testing a new drug called denikitug, alone or combined with other cancer drugs, in 120 people with advanced HER2-negative stomach, gastroesophageal junction, or esophageal cancer that has worsened after initial treatment. The main goal is to see if the drug …
Matched conditions: HER2-NEGATIVE
Phase: PHASE2 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
New drug cocktail shows promise for Tough-to-Treat stomach cancer
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of two immunotherapy drugs (iparomlimab and tuvonralimab, together called QL1706) plus standard chemotherapy can help people with advanced HER2-negative stomach cancer that has low PD-L1 levels. The study will enroll 77 particip…
Matched conditions: HER2-NEGATIVE
Phase: PHASE2 • Sponsor: Qilu Hospital of Shandong University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC